These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9525837)

  • 1. Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats.
    Hughes CS; Vaden SL; Manaugh CA; Price GS; Hudson LC
    J Neurooncol; 1998 Mar; 37(1):45-54. PubMed ID: 9525837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates.
    Warren KE; Patel MC; McCully CM; Montuenga LM; Balis FM
    Cancer Chemother Pharmacol; 2000; 45(3):207-12. PubMed ID: 10663638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
    Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in P-glycoprotein expression in mouse tissues by doxorubicin: implications for pharmacokinetics in multiple dosing regimens.
    Gustafson DL; Long ME
    Chem Biol Interact; 2001 Oct; 138(1):43-57. PubMed ID: 11640914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.
    Fenart L; Buée-Scherrer V; Descamps L; Duhem C; Poullain MG; Cecchelli R; Dehouck MP
    Pharm Res; 1998 Jul; 15(7):993-1000. PubMed ID: 9688050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
    Colombo T; Zucchetti M; D'Incalci M
    J Pharmacol Exp Ther; 1994 Apr; 269(1):22-7. PubMed ID: 8169829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice.
    Zhao YL; Du J; Kanazawa H; Cen XB; Takagi K; Kitaichi K; Tatsumi Y; Takagi K; Ohta M; Hasegawa T
    Brain Res; 2002 Nov; 956(2):246-53. PubMed ID: 12445692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier.
    Sakata A; Tamai I; Kawazu K; Deguchi Y; Ohnishi T; Saheki A; Tsuji A
    Biochem Pharmacol; 1994 Nov; 48(10):1989-92. PubMed ID: 7986214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
    Salaroglio IC; Abate C; Rolando B; Battaglia L; Gazzano E; Colombino E; Costamagna C; Annovazzi L; Mellai M; Berardi F; Capucchio MT; Schiffer D; Riganti C
    Mol Pharm; 2019 Aug; 16(8):3361-3373. PubMed ID: 31265310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study.
    de Vries EF; Doorduin J; Vellinga NA; van Waarde A; Dierckx RA; Klein HC
    Nucl Med Biol; 2008 May; 35(4):459-66. PubMed ID: 18482683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity.
    Szalóki G; Krasznai ZT; Tóth Á; Vízkeleti L; Szöllősi AG; Trencsényi G; Lajtos I; Juhász I; Krasznai Z; Márián T; Balázs M; Szabó G; Goda K
    PLoS One; 2014; 9(9):e107875. PubMed ID: 25238617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats.
    Wang Q; Yang H; Miller DW; Elmquist WF
    Biochem Biophys Res Commun; 1995 Jun; 211(3):719-26. PubMed ID: 7598699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro.
    Dohgu S; Nishioku T; Sumi N; Takata F; Nakagawa S; Naito M; Tsuruo T; Yamauchi A; Shuto H; Kataoka Y
    Cell Mol Neurobiol; 2007 Nov; 27(7):889-99. PubMed ID: 17934807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats.
    Kageyama M; Namiki H; Fukushima H; Ito Y; Shibata N; Takada K
    Biol Pharm Bull; 2005 Feb; 28(2):316-22. PubMed ID: 15684491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
    Lopes EC; Scolnik M; Alvarez E; Hajos SE
    Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of drugs with P-glycoprotein in brain capillaries.
    Jetté L; Murphy GF; Leclerc JM; Beliveau R
    Biochem Pharmacol; 1995 Nov; 50(10):1701-9. PubMed ID: 7503774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T
    Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.
    Lazarowski A; Ramos AJ; García-Rivello H; Brusco A; Girardi E
    Cell Mol Neurobiol; 2004 Feb; 24(1):77-85. PubMed ID: 15049512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.
    Kemper EM; van Zandbergen AE; Cleypool C; Mos HA; Boogerd W; Beijnen JH; van Tellingen O
    Clin Cancer Res; 2003 Jul; 9(7):2849-55. PubMed ID: 12855665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues.
    Jetté L; Beaulieu E; Leclerc JM; Béliveau R
    Am J Physiol; 1996 May; 270(5 Pt 2):F756-65. PubMed ID: 8928836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.